Calls for UK to stock up on antibody Covid drug that slashes risk of illness by up to 80%

Calls for UK to stock up on antibody Covid drug that slashes risk of illness by up to 80% Britain must urgently build up stocks of a Covid drug that could be a lifesaver for half a million extremely vulnerable Britons, campaigners say.

Evusheld, developed by AstraZeneca, will allow people who were less likely to get an immune response from the Covid vaccines to return to normal life, they claim.

The twice-yearly injection was approved by drug regulators in March after a study showed it slashed the risk of falling will with Covid by nearly 80 per cent. The Daily Mail

See also:

• HMP Lewes Covid measures 'not humane', says watchdog BBC News
• How will Boris Johnson’s handling of the Covid crisis be remembered? The Guardian
• NHS staff criticise 'incomprehensible' scrapping of special Covid leave The Independent
• NHS to enforce mask wearing as Covid hospital infections rise 100% The Independent
• Covid hospital patients nearing peak of spring wave The Independent
• UK Covid cases soar to record high as public vigilance slumps after Partygate scandal iNews
• COVID-19: New wave of Omicron mutations spreading across Europe, EU Medicines Agency warns Sky News